Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ERENUMAB-AOOE Cause Wound infection? 585 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 585 reports of Wound infection have been filed in association with ERENUMAB-AOOE. This represents 1.2% of all adverse event reports for ERENUMAB-AOOE.

585
Reports of Wound infection with ERENUMAB-AOOE
1.2%
of all ERENUMAB-AOOE reports
585
Deaths
516
Hospitalizations

How Dangerous Is Wound infection From ERENUMAB-AOOE?

Of the 585 reports, 585 (100.0%) resulted in death, 516 (88.2%) required hospitalization, and 525 (89.7%) were considered life-threatening.

Is Wound infection Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ERENUMAB-AOOE. However, 585 reports have been filed with the FAERS database.

What Other Side Effects Does ERENUMAB-AOOE Cause?

Accidental exposure to product (9,923) Device difficult to use (9,530) Wrong technique in product usage process (9,359) Drug dose omission by device (6,340) Migraine (4,290) Drug ineffective (3,813) Constipation (3,104) Product storage error (2,958) Headache (2,787) Injection site pain (2,715)

What Other Drugs Cause Wound infection?

ADALIMUMAB (1,822) METHOTREXATE (1,607) RITUXIMAB (1,598) TOCILIZUMAB (1,478) DICLOFENAC (1,410) SECUKINUMAB (1,393) ABATACEPT (1,382) PREDNISONE (1,335) LEFLUNOMIDE (1,328) INFLIXIMAB (1,317)

Which ERENUMAB-AOOE Alternatives Have Lower Wound infection Risk?

ERENUMAB-AOOE vs ERENUMAB\ERENUMAB-AOOE ERENUMAB-AOOE vs ERGOCALCIFEROL ERENUMAB-AOOE vs ERGOCALCIFEROL\PHYTONADIONE\RETINOL\TOCOPHEROL ERENUMAB-AOOE vs ERIBULIN ERENUMAB-AOOE vs ERLOTINIB

Related Pages

ERENUMAB-AOOE Full Profile All Wound infection Reports All Drugs Causing Wound infection ERENUMAB-AOOE Demographics